The Late-stage ELISA Support (LES) group under the Pre-Clinical Antibody and Assay Development (PAAD) team executes potency assay development and analytical testing to support lead molecule development from Pre-IPA through BLA. The team develops fit‑for‑purpose assays, supports clinical and regulatory programs, and partners with internal drug development, manufacturing, and quality control stakeholders to enable drug substance (DS), drug product (DP) through stability and IV admixture testing, among other sample studies.

**Responsibilities during a typical day might include the following:**

+ Perform potency testing of manufacturing, QC, and stability samples.
+ Design, develop, and optimize binding and blocking ELISAs to support potency testing of lead protein therapeutics across research and clinical programs.
+ Analyze and interpret data using GraphPad Prism and Excel; clearly summarize results for stakeholders.
+ Maintain accurate, thorough laboratory doc...